METHYL 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXYLATE 1,1-DIOXIDE
UNII Z7C4J6BW2K

Substance Identification & Data

This profile provides standardized clinical and technical data for Methyl 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z7C4J6BW2K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 35511-15-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Z7C4J6BW2K

CAS Registry Number

35511-15-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

METHYL 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXYLATE 1,1-DIOXIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C11H11NO5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NGHIOTWSWSQQNT-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

54676532

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S1(N(C(=C(c2c1cccc2)O)C(=O)OC)C)(=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Methyl 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.